Daily treatment with doxycycline did not shorten recovery time or reduce hospitalization or death in community-dwelling older adults with COVID-19, according to a study from the PRINCIPLE Collaborative Group.
Same-day pre-event screening for SARS-CoV-2 using antigen-detecting rapid diagnostic tests (Ag-RDT) may enable the resumption of large-scale indoor events which were halted or had their attendance capacity reduced during the COVID-19 pandemic, according to a study from Spain presented at ECCMID 2021.
The addition of azithromycin to standard care did not reduce hospitalization or mortality risk in patients with mild-to-moderate COVID-19 who underwent ambulatory management, according to results of the ATOMIC2 trial presented at ECCMID 2021.
Universal access to direct-acting antivirals (DAAs) may have led to the low prevalence of hepatitis C viraemia among people living with HIV (PLHIV) in The Netherlands, according to a study presented at IAS 2021.
The combined regimen of bedaquiline, pretomanid, and linezolid (BPaL) may help treat highly drug-resistant tuberculosis (TB), even with lower doses or shorter treatment duration of linezolid, according to results of the phase III ZeNix trial presented at IAS 2021.